On the other hand, as contributions of the present study, protocols applicable in clinical contexts are suggested, with the adoption of approaches with a smaller number of sessions and more detailed clinical evaluations of participants regarding any symptoms of infections, vaccination status, or lack of immune response to justify better control of LT-CD4+ and LT-CD8+ counts. This evidence concerns the gene CD4 and infection.